Navigation Links
Making the World A Brighter Place - DENTCA Provides High Quality CAD/CAM Dentures in Five Days and Just Two Visits.
Date:5/28/2013

Los Angeles, California (PRWEB) May 28, 2013

DENTCA, Inc., the worldwide leader in 3D denture design and production, is happy to announce system-wide improvements that further revolutionize modern denture production for greater accuracy, quality, and convenience. Imagine if doctors can meet with a patient just twice to deliver the most accurate dentures available today. Imagine if the entire impression to final denture production process takes five working days and only one hour of chairtime before final delivery. New system improvements now enable DENTCA to produce final dentures with the highest quality 3D modeling and accuracy in just five working days. If doctors want to test the fit, retention, aesthetics, and occlusion before finalizing the dentures, try-in dentures are available in just three working days after receiving the original impression.

Before DENTCA’s innovative technology was introduced to dentistry in January 2012, manufacturing conventional dentures had been time-consuming and full of human error. Oftentimes, the end result would be uncomfortable for the denture patient, even after multiple final adjustments. DENTCA’s innovative CAD/CAM technology has changed this process in all dimensions. Using 3D mapping technology similar to those employed by Hollywood’s top special effects artists, DENTCA is able to achieve a 100% accurate fit after only one patient visit. The first patient visit consists of taking the impression, bite registration, and lip ruler measurement – with no further measurements needed to deliver the most accurate, high quality, comfortable final dentures. As an added benefit, the digitized information is permanently stored in the DENTCA database, so 100% accurate and identical replacement dentures can be made at any time without additional time needed by the doctor.

As many denture patients find it difficult to schedule multiple doctor visits, DENTCA’s two-visit system makes th
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Decision making preferences among patients with heart attacks
2. Soap Making Recipes
3. “Soap Making Fun” Teaches People How To Make Soap Naturally And Beautifully – V-kool
4. Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants
5. STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds
6. Addiction as a disorder of decision-making
7. Americans Still Making Unhealthy Choices: CDC
8. Study Finds Overweight Young Males Have a Greater Risk of Not Surviving Until Age 55, Making Weight Loss Supplements Like Prescopodene Helpful With Increasing Longevity
9. New Study Reveals that Fitness Levels May Affect Attention Span, Making Weight Loss, Such as With Prescopodene, Helpful With Promoting Concentration
10. Body Mint-USA Introduces Chemical and Aluminum-Free Odor Solution Making It a Natural Deodorant Choice
11. New Study Reveals that Late Night Food Intake Hinders Weight Loss, Making Weight Loss Supplements Like Prescopodene Helpful With Shedding Excess Pounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Novation, the nation’s largest ... pharmacogenetic lab testing and precision medicine solutions that can help pharmacists and other ... more than 8.6 million adverse drug events are reported in the U.S. ...
(Date:8/3/2015)... ... 2015 , ... Dental practice in Los Angeles , Sunset Plaza Dental, ... that general health emergencies, such as broken arms or a heart attack, should be ... turn to during a dental emergency. This is important, because dental trauma is extremely ...
(Date:8/3/2015)... ... August 03, 2015 , ... Results of a comprehensive ... Healthcare Research and Policy Analysis show widespread support for the U.S. Affordable Care ... or strongly agreed that the controversial law passed in 2010 had “more good ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... The U.S. ... under the chin. Kybella is similar to deoxycholic acid, which occurs naturally in the ... the main options to treat this area of the body. These are invasive procedures ...
(Date:8/3/2015)... ... 03, 2015 , ... Illinois Health & Science (IHS) has completed the purchase ... includes all of IBAM NA’s cyclotron sites and research and development facilities. ... business, as well as a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, ...
Breaking Medicine News(10 mins):Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2
... Palomar Medical Technologies, Inc. (Nasdaq: PMTI ), ... treatments, will hold its quarterly conference call of its 2009 ... 11:30 AM Eastern Time. If you would like to participate, ... that day. The telephone replay will be available one hour ...
... , TAMPA, Fla., July 23 Bay Area ... chemical drugs and armed himself with a movie to help ... preventable illness, Burton found an alarming connection between America,s food ... Now he,s going to tell the world what he found. ...
... what a tale my thoughts could tell" Gordon Lightfoot ... and some new businesses, are banking on a brain imaging ... hidden thoughts, such as lies, truths or deep desires. ... Rutgers University provides evidence that fMRI can be used in ...
... risen over recent years. This is fact, but what is ... health centres have shown that family conflict is not a ... Primaria are striking: in Spain, 24% of women take antidepressants ... of psychopharmaceuticals is often related to family or work-related problems. ...
... , PRINCETON, N.J., July 23 The National ... several member associations today urged President Obama and members of Congress to ... most pervasive and costly diseases, a priority in reforming the U.S. healthcare ... to the President and lawmakers, NCDP said a national response to diabetes ...
... , BATESVILLE, Ind., July 23 Hill-Rom Holdings, Inc.,s, ... be issued Thursday, August 6, 2009. You are invited to participate ... a.m. EDT. , Earnings Release: Hill-Rom Holdings, ... 2009 will be released to the public after the NYSE close on ...
Cached Medicine News:Health News:Palomar Medical Technologies To Host Second Quarter 2009 Financial Results Conference Call and Webcast on July 30, 2009 2Health News:Nurse Turned Filmmaker Makes Lifesaving Film 2Health News:Can brain scans read your mind? 2Health News:Can brain scans read your mind? 3Health News:Almost 1 quarter of Spanish women take antidepressants 2Health News:NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care 2Health News:NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care 3Health News:Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Third Quarter Earnings Webcast 2
(Date:8/3/2015)... 3, 2015  Array BioPharma Inc. (NASDAQ: ... quarter and full year of its fiscal year ... Chief Executive Officer of Array, noted, "Binimetinib and encorafenib, ... on track for regulatory submissions in 2016. Additional ... and BRAF-mutant colorectal cancer further validate the value ...
(Date:8/3/2015)... Aug. 3, 2015  Charleston Laboratories, Inc., an ... second clinical development program with a Phase 1 ... CL-H1T contains fast-dissolving promethazine and sumatriptan.  ... a treatment for migraine headache pain and migraine-induced ... patients with migraine headaches also suffer from nausea ...
(Date:8/3/2015)... FLORHAM PARK, N.J. , Aug. 3, ... met its primary and secondary endpoints in a phase ... constipation (OIC) in adult patients with chronic non-cancer pain. ... antagonist (PAMORA). This is the third Phase III trial ... endpoints. Study results showed that a 0.2 ...
Breaking Medicine Technology:Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4
... Diagnostics Incorporated (NYSE: DGX ), the world,s leading ... its Board of Directors declared a quarterly cash dividend of ... of record of Quest Diagnostics common stock on April 3, ... Quest Diagnostics is the world,s leading provider of diagnostic testing, ...
... 28, 2012 HistoRx, the leader in quantitative ... technology and critical elements of digital microscopy standardization.  ... the US Patent & Trademark Office advance the ... pathology to a dominant role in the industry.  ...
Cached Medicine Technology:HistoRx Achieves Dominant Intellectual Property Position in Standardization of Results from Digital Pathology Instruments 2HistoRx Achieves Dominant Intellectual Property Position in Standardization of Results from Digital Pathology Instruments 3
This portable resource provides definitions for medical acronyms and abbreviations....
Stedman's Medical Dictionary includes charts and tables and navigation and search tools....
With Skyscape's smARTlink technology, Tabers can cross-index with other clinical and drug prescription products from Skyscape to provide an integrated source of clinical information....
CPTMeister is a coding reference based on the Physicians' Current Procedural Terminology (CPT) codes developed by the American Medical Association. It is an iSilo document composed of more than 2,000...
Medicine Products: